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SUMMARY 
This report describes the results of a 2nd collaborative study of an HPLC method for the 
coccidiostat narasin in one premixture. The collaborative study forms part of the EU-project 
"Development and Validation of HPLC-methods for the official control of Coccidiostats and 
Antibiotics used as Feed Additives (CANFAS-SMT4-CT98-2216). 
The results of the first collaborative study showed that the method can be successfully applied to 
feeds with narasin contents in the range of 20-120 mgAg, but that the reproducibility of the 
method was not satisfactory for the premixture (the HORRAT ratio for the premixture was too 
high). During the evaluation meeting it was decided that for premixtures a new small collaborative 
study had to be organised with a modified method. 
The principle of both the original and the modified method is as follows: Narasin is extracted using 
a mixture of methanol and phosphate buffer (90+10) with mechanical shaking. After dilution with 
mobile phase and filtration through a membrane filter, narasin is determined by reverse phase 
HPLC using post column derivatisation with dimethylaminobenzaldehyde (DMAB) in a solution 
containing sulphuric acid and detection at 600 nm. 
The declared content of narasin in the premixture that was prepared for the 2nd collaborative 
study was 1%. One single premixture was sent to the participants. The participants were asked to 
analyse the premixture in duplicate. Results were reported by 12 laboratories. Statistical 
evaluation was performed according to ISO 5725. 
During the first collaborative study satisfactory results for recovery, blind blank feed and 
feedingstuffs were obtained. The results of the second collaborative study show that with the 
modified method for premixtures acceptable results are obtained for repeatability (rsdr) and 
reproducibility (Horrat ratio <2). 
The final method can be recommended for adoption as an official method and together with the 
results of the collaborative studies it will be sent to the European Commission (CEMA), CEN and 
ISO. 
1 INTRODUCTION 
Within the framework of the EU-project "Development and Validation of HPLC-methods for the 
official control of Coccidiostats and Antibiotics used as Feed Additives (CANFAS-SMT4-CT98-
2216), a method was developed for narasin. Narasin is a coccidiostat which is registered for 
broiler feeds at contents of 40 - 50 or 60 - 70 mgAg. 
The method for feeds and premixtures was developed and validated by by LUFA - Augustenberg, 
Karlsruhe, Germany (see Final report on development and validation of a HPLC-method to 
determine narasin in feedstuffs, A. Thalmann, 29-10-1999). Subsequently, the method for feeds 
and premixtures was subjected to between-lab validation by the Danish Plant Directorate, Lyngby, 
Denmark (see report A. Pl0ger, 23-11-1999) and the State Laboratory, Dublin, Ireland (see report 
P. Shearan, January 2000) with satisfactory results (see Second Annual Report CANFAS, J. de 
Jong, 12-08-2000). 
Prior to the first collaborative study, a kick-off meeting was organised (Brussels, 13-14/6/2000) 
and participating laboratories were given the opportunity to familiarise themselves with the 
method, using feed samples with stated contents of narasin. Also prior to the production of the 
materials for the collaborative study, separate batches of the materials were produced for 
stability testing, indicating that narasin is stable in feeds and premixtures at room temperature for 
4 months. 
The results of the first collaborative study ("CANFAS - Collaborative study for the determination of 
narasin in feedingstuffs and premixtures by HPLC", J.J.M. Driessen, M.J.H. Tomassen, J. de Jong, 
RIKILT report 2002-015) showed that the reproducibility of the method was not satisfactory for 
the premixture (the HORRAT ratio for the premixture was too high). During the evaluation meeting 
organised after the 1st collaborative study it was decided that a new small collaborative study had 
to be organised with a modified method. 
The declared content of narasin in the premixture that was prepared for the collaborative study 
was 1%. One single sample was sent to the participants. The participants were asked to analyse 
the sample in duplicate. 
Before the sample was shipped, the between- and within-sample homogeneity was checked with 
satisfactory results (see par. 3.1.2). 
Apart from the samples, a letter with instructions, reporting forms, etc. was sent to the 
participants (see Appendix 1). Later on, an e-mail was sent to the partners with additional 
information. In this e-mail the participants were instructed not to take note of the moisture content 
of the standard and not to look at the factors D and I of narasin (see Appendix I). 
This report describes the results of the 2nd collaborative study. 
2 PARTICIPANTS 
The following laboratories/persons participated in the collaborative study. 
- Danish Plant Directorate, Lyngby, Denmark; A. Pteger, L. Junggreen 
- IEEB, Bordeaux, France; J.P. Antalick, C. Fiette 
- INETI/DTIA, Lisbon, Portugal; I. Felgueiras, R. Novo 
- Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy; G. Biancotto, B. Allegretta 
- Laboratory of the Government Chemist, Teddington, United Kingdom; J. Cowles 
- LUFA-ITL Kiel, Kiel, Germany; H. Wehage, Kollwitz 
- Masterlab, Putten, The Netherlands; K. van Schalm, B. Wolters 
- Plant Production Inspection Centre Agricultural Chemistry Department, Vantaa, Finland; R. 
Muhonen, T.Heikkinen 
- Rijksontledingslaboratorium, Tervuren, Belgium; K. Haustraete, A. Fontaine, M. Lekens, A. 
Voets 
- RIKILT, Wageningen, The Netherlands; H.J. van der Kamp, H.C.H. Kleijnen 
- Staatliche Landwirtschaftliche Untersuchungs- und Forschungsanstalt (LUFA), Augustenberg, 
Germany; A. Thalmann, K. Wagner 
- State Laboratory Dublin, Ireland; P. Shearan 
3 MATERIALS 
3.1 Sample for collaborative study 
3.1.1 Sample composition 
Specifications of the premixture, which was produced for the collaborative study, are given in 
Table 1. 
Table 1 : Specifications of the premixture 
Type of feed 
Premixture 
Declared 
content 
1 
Units 
% 
Subcontractor 
Trouw-Nutrition, Putten (NL) 
Date of 
production 
October 2001 
The premixture was based on inorganic material and contained regular contents of vitamins, 
minerals and trace elements. The composition of the premixture is enclosed in Appendix 2. 
For logistic reasons, the premixture was not prepared by SDS-Trouw, Witham (UK), as in the first 
round of collaborative studies and in the stability trial (see report on homogeneity and stability of 
narasin in broiler feeds and premix, A. Thalmann, LUFA-Augustenberg, 27/06/2000), but by 
Trouw Nutrition, Putten, the Netherlands. Although the composition of the premixture is not 
exactly the same, both premixtures are based on inorganic material (ca. 50%) and for this 
reason the stability of narasin is sufficiently guaranteed. 
The premixture was prepared in a quantity of about 3 kg. TNO-Voeding, Zeist, the Netherlands, 
performed the subsampling with an automatic sample device that resulted in about 30 PE 
bottles containing about 100 g of premixture each. The bottles were stored at room 
temperature prior to forwarding them to the participants. 
3.1.2 Sample homogeneity 
The homogeneity of the samples was studied by LUFA Augustenberg by random selection of 10 
subsamples per premixture, applying the HPLC-method developed in CANFAS (see Annex 1 of 
Appendix 1). 
The results of the homogeneity determinations of the premixture are attached in Appendix 2. 
Table 2 gives a summary of these results. 
Table 2: Results of homogeneity tests for narasin in the premixture 
\ . Results 
Products. 
Premixture 
Declared 
content 
1% 
Measured 
content 
1,06% 
Homogeneity results 
Between 
sample CV (%) 
3,1 
Within sample 
CV (%) 
3,2 
According to the Project Plan the CV's for homogeneity should not exceed 2 times the CV's for 
repeatability (CVhom < 2 CVr). Based on previous results of within-lab validation (see Second 
Annual Report CANFAS, J. de Jong, 12-08-2000) the maximum limit for CVhom was set to 10 %. 
The between-sample CV fulfils these requirements. Thus, it is concluded that the premixture is 
sufficiently homogeneous. 
3.1.3 Sample logistics 
The premixture was dispatched in PE bottles, each containing approximately 100 grams. The 
codes of the samples are given in Appendix 3. The samples were sent to the participants by 
courier service from RIKILT on December 13, 2001. During transport no special precautions 
were taken with regards to the temperature of the samples. 
3.2 Reference standard 
The reference standard was supplied by Eli Lilly and Company. The purity of the reference 
standard (Lot Nr. RS 0302) is 963 mg microbiological activity per mg on an "as is" basis. The 
certificate of analysis is described in Appendix 4. In the covering letter sent with the samples and 
reference standard, the participants were instructed to take note of the microbiological potency 
and the moisture content of the standard, (see Appendix 1). Later on, by sending an e-mail to the 
participants, they were instructed ooi to take note of the moisture content (see Appendix 1). 
4 METHODS 
4.1 Method of analysis 
The method of analysis is included as annex 1 to Appendix 1. The participants were instructed 
that this method has to be used without any modifications. 
4.1.1. HPLC-conditions 
Various types of HPLC-columns were used (the column which is recommended in the method is 
a Hypersil ODS CI8, 250 x 4 mm Shandon, with a particle size of 4 urn). 
The mobile phase described in the method is a mixture of 900 ml methanol and 100 ml 
phosphate buffer pH 4. As far as reported, all laboratories used this mobile phase. 
The HPLC conditions (column and mobile phase) used by the participants are shown in Table 3. 
4.2 Method for statistical evaluation 
Statistical evaluation was performed according to ISO 5725 Part 2: Basic method for the 
determination of repeatability and reproducibility of a standard measurement method (First 
edition, 1994-12-15). 
The scrutinity of results for consistency and outliers was checked by 
a) Graphical consistency techniques: Mandel's h plot for between-laboratory variability, Mandel's 
k plot for within-laboratory variability 
b) Numerical outlier techniques: Cochran's test of the within-laboratory variability, Grubbs' test 
(single and double) for between-laboratory variability 
Whenever necessary and appropriate, laboratories which showed consistently high within-cell 
variation and/or extreme cell means across many levels and/or Cochran or Grubbs' outliers were 
contacted to try to ascertain the cause of the discrepant behaviour. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility of the method. The HORRAT ratios are given in Table 4. The HORRAT ratios should 
be lower than 2 (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). 
Table 3: HPLC-conditions 
Partner 
11 
13 
23 
24 
26 
29 
30 
31 
33 
35 
37 
41 
Column 
As described in the method 
As described in the method 
Not reported 
Spherisorb C18; 5 urn; 250x4,6 mm 
Waters Spherisorb ODS-2; 5 urn; 
250x4,6 mm 
Nova-Pak C18; 4 urn; 4,6x250 mm 
Kromasil 150x4,6 mm 
As described in the method 
As described in the method 
Chromspher C18; 200x3,0 mm 
Hypersil BDS C18; 5 urn; 250x4,6 mm 
As described in the method 
Mobile phase 
As described in the method 
As described in the method 
Not reported 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
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5 RESULTS 
For each participant the reported results for the samples, the completed questionnaire and 
representative chromatograms are annexed in Appendix 5. 
5.1 Statistical evaluation 
Originally laboratory 33 reported results that were not in agreement with the results of the other 
participants and that deviated much from the theoretical narasin concentration. The reported 
results from lab 33 were 5800 and 5800 mg of narasinAg- Due to the magnitude of the 
deviations it was most likely that the results would cause outliers on both levels. Lab 33 was 
contacted to try to ascertain the cause of the discrepant behaviour. The lab recovered a mistake 
in the calculation of the results and asked to replace them by 12000 and 12000 mg/kg- Based 
on the explanation mentioned above it was decided to accept the new results. 
The results reported by the participants are given in Table 5. Figure 1 demonstrates the Mandel h 
and k plots of these results. 
Statistical analysis shows that the results do not contain Cochran or Grubb's outliers or 
stragglers. The resulting values for the statistical parameters (mean, relative standard deviation 
for repeatability and reproducibility) are given in Table 5. According to the Project Plan, the rsdr-
values should be < 10 %. This criterion is met and consequently it can be concluded that the 
repeatability is satisfactory. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). The HORRAT ratio is 
given in Table 4. The HORRAT ratio is lower than 2. Consequently it can be concluded that the 
reproducibility of the method is satisfactory for premixtures. 
Table 4: Horrat ratios of the Narasin collaborative study 
Mean (mgAg) 
10714 
Predicted rsdR 
3,959 
Established rsdR 
6,158 
Horrat1 
1,56 
Conclusion 
Reproducibility OK 
1
 Horrat is the ratio between the established rsdR and the predicted rsdR 
H 
Table 5: Results reported by the participants 
Lab 
11 
13 
23 
24 
26 
29 
30 
31 
33 
35 
37 
41 
Sample 
113106 
133123 
233121 
243117 
263124 
293107 
303118 
313114 
333103 
353122 
373115 
413116 
Result (mg/kg) 
NAR 10000 mgAg 
10267 
10667 
12000 
10801 
11887 
10935 
10320 
10779 
12000 
^_ 10812 
10560 
9976 
10495 
10713 
10800 
9950 
10612 
9902 
10260 
10778 
12000 
10539 
9960 
10122 
Summary of all results 
number of labs 
m (mgAg) 
rsdr(%) 
rsdR (%) 
12 
10714 
4,415 
6,158 
12 
Figure 1: Mandel h and k plots of the results reported by the participants 
11 13 23 24 26 29 30 31 33 35 37 41 
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5.2 Recoveries 
Table 6: Recoveries 
Partner 
11 
13 
23 
24 
26 
29 
30 
31 
33 
35 
37 
41 
Spiking level 
(mgAg) 
50 
Not reported 
Not reported 
50 
200 
50 
Not reported 
50 
1000 
50 
100 
Recovery 1 in % 
90 
Not reported 
Not reported 
96 
99 
102 
Not reported 
102 
103 
106 
89 
98 
Recovery 2 in % 
112 
Not reported 
Not reported 
99 
Not reported 
105 
90 
101 
recovery average in 
% 
101 
Not reported 
Not reported 
96 
99 
101 
Not reported 
102 
103 
106 
90 
100 
The laboratories reported recoveries of 89% or higher. In task 1 and 2 of the project (within- and 
between-lab validation) recoveries of 86% and higher were measured. 
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5.3 Remarks 
Table 7: Remarks made by the partners 
Partner 
11 
13 
23 
24 
26 
29 
30 
31 
33 
35 
37 
41 
Remarks 
No remarks. 
No remarks. 
Not reported 
The pump for the reagent of the derivatisation had technical problems. 
We injected the premixtures at 50 and 100 times dilutions because the level was 
unknown and to try and ensure that we did not have to repeat the work because the 
response was outside the range of the top calibrant standard. 
No remarks. 
No remarks. 
We calculated with a microbiological activity of 963 mcg/mg. The moisture content of 
2.13% was not taken into account. 
No remarks. 
No remarks. 
No remarks. 
No remarks. 
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6 CONCLUSIONS 
The results of the second collaborative study show that with the modified method for premixtures 
acceptable results are obtained for repeatability (rsdr) and reproducibility (Horrat ratio <2). So, it 
can be concluded that the modified method is suitable for premixtures. 
From the results of the first collaborative study it was already concluded that the repeatability and 
reproducibility of the method for feedingstuffs was acceptable. The results obtained for the 
recovery and for the blind blank samples were also satisfactory. 
The final method can be recommended for adoption as an official method and together with the 
results of the collaborative studies it will be sent to the European Commission (CEMA), CEN and 
ISO. 
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APPENDIX 1 
Letter with instructions, sent with the samples (with five annexes) and e-mail with 
additional information 
Participants CANFAS collaborative study Narasin 
Dear colleague, 
As agreed at the CANFAS evaluation meeting June 20th, 2001 at Tervuren a second 
round of collaborative study for narasin in a premixture has to be organised. We 
appreciate your willingness to participate very much. Together with this letter you will 
find: 
• 1 sample of premixture labeled with the text "additive: NARASIN" and with a sample 
code. The sample contains narasin in the range between 0.5 and 3%. 
• the modified method of analysis (annex 1). By participation you agree with 
application of this method! 
• the reporting form (annex 2). This form will also be send to you by E-mail as an 
Excel 5.0 file. We strongly prefer to get the results back in electronic form by E-
mail; you are asked to use the e-mail address mentioned in the right margin of this 
letter. 
• instructions for handling (storage) of the samples (annex 3). 
• a questionnaire (annex 4). We kindly ask you to give us information about the 
experimental conditions, recoveries, etc.. On this form you can also give your 
remarks about the method. 
• a second questionnaire (annex 5) regarding the factors of narasin 
The sample must be analysed in duplicate. 
For recovery purposes we ask you to use a sample from your own collection. 
Because the reference standard that was sent to you in 2000 by mr. Towell (Eli Lilly) has 
expired you receive together with the premixture a new Eli Lilly reference standard of 
narasin, lot number RS0302, that has to be used at the analyses. Please take note of the 
microbiological potency and the moisture content of this standard (see Annex 5). 
The deadline for reporting the results is January 25, 2002. 
We wish you and your colleagues the best with the collaborative study. If you have any 
questions, do not hesitate to contact us. 
DATE 
13 December 2001 
SUBJECT 
CANFAS collaborativi 
narasin (71316.24) 
ENCLOSURE(S) 
4 
OUR REFERENCE 
01/0030596 
HANDLED By 
Ing. J.J.M. Driessen 
DIRECT (TELEPHONE! LINE 
+31 317 47 55 74 
E-MAIL 
j.j.m.drie»«en@rikilt.v 
RIKILT 
State Institute for Qui 
Control of Agriculture 
Products 
P.O.Box 230 
6700 AB Wageninget 
The Netherlands 
VISITORS' ADDRESS 
Building no. 123 
Bornsesteeg 45 
6708 PD Wageningei 
TELEPHONE 
+31 317 47 54 00 S 
FAX 
+31 317 41 77 17 
CHAMBER OF COMMERCE REGISTI 
09098104 te Arnhem 
THE INTERNET 
www.rikilt.wageningei 
Kind regards, 
dr. J. de Jong 
CANFAS co-ordinator 
ing. J.J.M. Driessen 
co-ordinator CANFAS collaborative 
studies 
CANFAS/NAR/28112001/A.THALMANN 
Annex 1 - the modified method of analysis 
Determination of Narasin with High Performance Liquid Chromatography (HPLC) 
1 Scope 
The method serves for the quantitative determination of Narasin sodium in 
feedstuffs, premixtures and concentrates. The limit of determination is 20 mg/kg, the 
limit of detection 1 mg/kg. 
2 Principle 
Narasin is extracted using a mixture of methanol and phosphate buffer (90+10) with 
mechanical shaking. After dilution and filtration through a membrane filter narasin is 
determined by reverse phase HPLC using post column derivatisation with 
dimethylaminobenzaldehyde in a solution containing sulphuric acid and detection at 
600 nm. 
3 Reagents 
3.1 Methanol - HPLC grade 
3.2 di-potassiumhydrogenphosphate, waterfree 
3.3 di-potassiumhydrogenphosphate solution, c (K2HP04) = 0.05 mol/1 water 
3.4 Potassiumdihydrogenphosphate, waterfree 
3.5 Potassiumdihydrogenphosphate solution, c (KH2P04) = 0.01 mol/1 water 
3.6 1,5-dimethylhexylamine (6-methyl-2-heptylamine, CgH19N) 
3.7 Ortho-phosphoric acid, w (H,P04) = 85 % 
3.8 Sulphuric acid, w (H2S04) = 95-97 % 
3.9 4-(dimethylamino)-benzaldehyde (DMAB, C9H,,NO) 
3.10 Extraction solvent: 900 ml methanol (3.1 ) are mixed with 100 ml di-
potassiumhydrogenphosphate solution (3.3). 
3.11 Phosphate buffer: To 500 ml solution of potassiumdihydrogenphosphate (3.5) 3.0 ml 
o-phosphoric acid (3.7) and 10.0 ml 1,5-dimethylhexylamine (3.6) are added. The pH 
is adjusted to 4.0 with o-phosphoric acid, and the solution is made up to 1000 ml 
with water. 
3.12 Mobile phase: 900 ml methanol (3.1) are mixed with 100 ml phosphate buffer (3.11). 
The solution is degassed prior to use in an ultrasonic bath (8.3) during 15 min. 
3.13 Methanol-sulphuric acid: 40 ml sulphuric acid (3.8) are given cautiously while 
stirring to 950 ml methanol (3.1). The solution is degassed prior to use in an 
ultrasonic bath (8.3) during 15 min. 
3.14 DMAB-solution: 60.0 g dimethylaminobenzaldehyde (3.9) are solved in 950 ml 
methanol (3.1). The solution is degassed prior to use in an ultrasonic bath (8.3) 
during 15 min. 
3.15 Narasin-sodium reference standard (monocarboxylic acid-polyether-sodium salt, 
C43H7iNaOn) with defined microbiological activity and factor composition. 
3.16 Narasin-stock solution, 250 ug/ml 
An amount of Narasin-sodium (3.15) equivalent to 25.00 mg microbiological activity 
is solved in 100 ml methanol (3.1). The solution is stable for 4 weeks if kept at >0 - < 
10 °C. 
4 Apparatus 
K:\canfas\tweede ringstudie\0030596al .doc 
4.1 HPLC-system consisting of: 
4.1.1 Pump - pulse free, flow capacity 0.1-2.0 ml/min 
4.1.2 Injection system, manual or autosampler with loop suitable for 100 ul injections 
4.1.3 Post-column reactor (double pump or two single pumps) with mixing chamber, 
reaction coil of inert material (f.e. Teflon or Peek) for operation at 93 °C, 7.0 m with 
0.33 mm ID and water bath or reactor oven for operation at 93 °C 
4.1.4 VIS-detector, variable wavelength, suitable for measurements at the wavelength of 
600 nm 
4.1.5 Analytical column - 4 urn CI8 Hypersil ODS, 250 x 4 mm f.e. Shandon or 
equivalent (8.2) 
4.2 Magnetic stirrer or mechanical shaker 
4.3 Ultrasonic water bath 
4.4 Membrane filter of Teflon, pore diameter 0.45 um 
4.5 Commercially available equipment 
5 Procedure 
5.1 General 
5.1.1 Blank feed 
For the performance of the recovery test (5.1.2) a blank feed should be analysed to 
check that neither Narasin nor interfering substances are present. The blank feed 
should be similar in type to that of the sample and Narasin or interfering substances 
should not be detected. 
5.1.2 Recovery test 
A recovery test should be carried out by analysing the blank feed which has been 
fortified by addition of a quantity of Narasin, similar to that present in the sample. To 
fortify at a level of 50 mg/kg transfer 4 ml of the stock solution (3.16) to a conical 
flask and evaporate the solution to approximately 0.5 ml. Add 20 g of the blank feed, 
mix thoroughly and leave for 10 minutes mixing again several times before 
processing with the extraction step (5.2). 
Alternatively, if a blank feed similar in type to that of the sample is not available 
(5.1.1), a recovery test can be performed by means of the standard addition method. 
In this case, the sample to be analysed is fortified with a quantity of Narasin similar 
to that already present in the sample. This sample is analysed together with the 
unfortified sample and the recovery can be calculated by subtraction. 
5.1.3 Mixing of the test sample before weighing 
The container should be filled to a maximum of 50 % of its total volume. Bring 
the container in a horizontal position and rotate bottom and top in circles 
moving it up and down along its virtual centre for about 30 seconds. Put the 
container in an upright position and wait a few seconds to let the generated dust 
settle. 
K:\canfas\tweede ringstudie\0030596al .doc 
5.2 Extraction 
5.2.1 Premixtures 
5.0 g are weighed into a 500-ml-Erlenmeyer flask, 200 ml extraction solvent 
(3.10) added, treated 5 min in the Ultrasonic water bath and stirred on a 
magnetic stirrer or shaken on a mechanical shaker (4.2) for 1 h. Let settle the 
coarse particles. The extract is diluted subsequently with mobile phase (3.12) to 
4.0 ug/ml and filtered through a membrane filter (4.4). 
5.2.2 Final feeds 
20.0 g are weighed into a 250-ml-Erlenmeyer flask, 100 ml extraction solvent (3.10) 
added, treated 5 min in the Ultrasonic water bath and stirred on a magnetic stirrer or 
shaken on a mechanical shaker (4.2) for 1 h. Let settle the coarse particles. The 
extract is diluted subsequently to 1.0 ug/ml with mobile phase (3.12) and filtered 
through a membrane filter (4.4). 
5.3 HPLC procedure 
The following conditions are offered for guidance, other conditions may be used 
provided that they give equivalent results. 
Narasin is separated on a reversed phase column (4.1.5), detected and its 
concentration measured after post-column reaction (4.1.3) with a UV-Detector 
(4.1.4) at 600 nm. 
A aliquot of the sample solution (5.2), f.e. 100 ul is injected on the separation 
column and eluted with the mobile phase (3.12). The mean heights of the peaks resp. 
the areas of several injections of the calibration solutions (5.4.2) are measured. 
HPLC-conditions 
Column (4.1.5) Hypersil ODS, 250 x 4 mm, 5 um 
Mobile phase (3.12) Mixture of 900 ml methanol (3.1) 
+ 100 ml phosphate buffer (3.11) 
Flow rate of mobile phase 0.7 ml/min 
Flow rate of methanol-sulphuric acid-mixture (3.13) 0.4 ml/min 
Flow rate of DMAB-solution (3.14) 0.4 ml/min 
Temperature of the post-column reaction 93 °C 
VIS-Detector after post-column reaction 600 nm 
Volume of injections 100 ul 
Calculation Height or area of peak 
5.4 Calibration curve 
5.4.1 Preparation of the working standard solution: 10 ml the stock solution (3.16) are 
diluted with the extraction solvent (3.10) to 100 ml. The concentration of narasin-
sodium is w = 25 ug/ml. The solution is stable for 4 weeks if kept at >0 - < 10 °C. 
5.4.2.1 Preparation of the calibration solution for concentrations 200 mg/kg: 5.0,10.0, 
20.0 and 40.0 ml of the working standard solution (5.4.1) are pipetted into a 100-
ml-volumetric flask each, filled up with mobile phase (3.12) and mixed. The 
concentration of narasin-sodium corresponds to = 1.25; 2.50; 5.00, and 10.00 
ug/ml. 
The calibration solutions have to be prepared daily. 
5.4.2.2 Preparation of the calibration solution for concentrations 200 mg/kg: 1.0, 2.0, 4.0 
and 8.0 ml of the working standard solution (5.4.1) are pipetted into a 100-ml-
K:\canfas\tweede ringstudie\0030596al .doc 
volumetric flask each, filled up with mobile phase (3.12) and mixed. The 
concentration of narasin-sodium corresponds to = 0.25, 0.50, 1.00 and 2.00 ug/ml. 
The calibration solutions have to be prepared daily 
5.4.3 Preparation of the calibration curve 
100 ul each of the calibration solutions (5.4.2) are injected and the mean height or 
area of the peaks of several injections measured. Under the above conditions the 
retention time of narasin is approximately 19 min. 
6 Calculation 
The concentration of narasin-sodium is calculated in mg/kg microbiological activity 
from the mean height or area of the peak of factor A in sample solution (5.3) and the 
calibration curve (5.4.3) based on the assumption that the relation of microbiological 
activity to content of factor A is the same in the feed additive and in the standard. 
The content w in the sample is calculated from the concentration received respecting 
weigh and dilution by means of the following formula: 
V * b * F 
w = mg/kg. 
V = volume of extractant in ml (200 ml for premixtures (see 5.2.1) and 100 ml for 
final feeds (see 5.2.2)) 
b = concentration of the sample solution in ug/ml microbiological activity of narasin-
sodium 
E = weigh of the sample in g 
F = factor of dilution 
7 Statistics 
(Will follow) 
8 Remarks 
8.1 Extraction 
Due to the addition of di-potassiumhydrogenphosphate to the extractant solvent with 
most of the samples it is possible to let stand the extracts over night at room 
temperature performing dilution and chromatography the following day. Since 
it may occur - especially in premixtures and mineral feeds - that there is a slight 
breakdown of narasin the analysis has to be repeated with shaking of the extract (or 
not more than 1 hour before chromatography. 
In a few feedstuffs it was observed that unknown compounds interfered with the 
retention time and peak shape in chromatograms when low concentrations (< 20 
mg/kg) of narasin were present. To overcome this difficulty 10 g of Alumina 90 
(Merck 1.01097 or equivalent) were added to the weigh. 
If interfering pharmaceutical agents are present the following procedure may be 
applied: 
Weigh 20.0 g sample into 250 ml Erlenmeyer flask. Add 100 ml hexane, stopper and 
shake for at least one hour on a wrist-action shaker. Filter sample solutions through 
42 Whatman filter or equivalent into 125-ml-Erlenmeyer flask. Pipet 20.0 ml of 
extract and evaporate to dryness on the nitrogen evaporator. Dissolve the residue in 
20.0 ml of extraction solvent. Introduce this solution into a prepared column with 10 
g Alumina 90. Filter a portion of the eluate before proceeding to the HPLC analysts. 
V Arnnfa<Afweerle rinf»studie\003f)59fia1 Hoc 
8.2 Separation material 
Baseline separation between narasin factor A and salinomycin must be obtained. 
Hypersil ODS 5 mm in a 250 x 4 mm steel column has been proven as the best one. 
It is possible to separate narasin from other polyether antibiotics and to get the peaks 
of the 4 main factors. Inertsil and Purospher can be recommended if there is doubt 
whether narasin is separated from other compounds. The retention times are longer 
than with Hypersil. 
8.3 Protection against corrosion 
All fittings, which come in contact to the methanol-sulphuric acid-mixture (3.13), 
should be made from Teflon, Peek or comparable material. 
8.4 Post-column reaction 
If only one pump for the post-column reaction is available the reagents 3.13 and 3.14 
may be mixed. Since DMAB undergoes quick auto-oxidation resulting in darkening 
of the solution this has to be kept protected from light in an ice bath and has to be 
used within 24 h. 
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ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Product: 
Task 4 COLLABORATIVE STUDY - 2nd round 
e-mail: 
fax: 
telephone: 
| NARASIN | 
| Premixture 
Unit 
Sample code 
Result 1 
(mg/kg) 
Result 2 
(mg/kg) 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 3 - Instructions for handling of the premixture sample 
1. Storage 
Store the sample at room temperature until analysis. Protect the samples from light. 
2. Milling (see par. 5.1) 
The sample must not be milled!! 
3. Mixing nf the test samples hefnre weighing (see par. 5.1) 
Bring the container in a horizontal position and rotate bottom and top of the container in circles moving the 
container up and down along the virtual centre of the container for 30 seconds. 
Put the container in an upright position and wait a few seconds for settlement of the generated dust. 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4 • Questionnaire 
Laboratory: 
Contact person: 
Date(s) of analysis: 
Chromatographic conditions: 
• Column: 
• As described in the method 
Other: 
• Mobile phase: 
• As described in the method 
• Other: 
• Flow-rate: ml/min 
• Injection volume: ul 
Chromatograms: Please include representative chromatograms of: 
• Premixture 
Please indicate the narasin factor Apeak (and the factor D/I peak, see Annex 5) with an arrow 
Recovery results; 
• Percentage recovery: % 
• Single / duplicate determinations: single duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: mg/kg 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4, page 2 
Remarks /Comments (if necessary, continue on another page) : 
Please complete this questionnaire and return it together with representative chromatograms to: 
Ing. J.J.M. Driessen 
RIKILT 
P.O. Box 230 
6700 AE Wageningen 
The Netherlands 
Fax+31-317417717 
Thank you for your cooperation ! 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 5 - Questionnaire 2 (narasin factors), page 1 
Eli Lilly reference Standard profile for Narasin 
Effective date: 
Expiry date: 
Lot number: 
Defined potency: 
Handling: 
Storage: 
Water: 
March 29, 2001 
March 28, 2003 
RS0302 
963 meg microbiological activity per mg on an 'as is' basis; 85.4% factor A, 1.9% 
factor D and 0.7% factor 1 on an 'as is' basis. 
Refer to current MSDS for handling and caution information. 
125 mg quantities in heat sealed amber glass ampoules with argon overlay at freezer 
temperature, -10 to -25 degrees C. 
2.13% 
Annex 5, page 2 • Questionnaire 2 (narasin factors) 
Laboratory: 
Contact person: 
Sample code: (please complete one annex for each sample) 
Weigh standard: 
Microbiological activity standard: 
Moisture content standard: 
Concentration of the stock standard solution (in microbiological activity): 
Dilution standard: 
Weigh sample: 
Dilution sample: 
The concentration of narasin is calculated from the peak of factor A (see paragraph 6 of the method). However 
we ask you to give information on the area of the peaks of the factors D and I as well (the peaks of factors D 
and I are indicated in the chromatogram attached). If you cannot detect the peaks of these factors in the 
standards or samples, please indicate with ND (= non detected). 
Factor A retention time (min) 
Standard3 
Sample 
Factor A peak height or area 
Standard [.../(ng/ml)]c 
Sample 
Content determined via factor A 
Factor D + 1 peak area (combined) 
Standard [.../(ng/ml)]d 
Sample 
Height / areab 
Area 
agive the range of retention times for the calibration solutions 
"indicate if you measured peak height or area 
cgive the mean peak height/area for the calibration solution containing 1 jig/ml, as derived from the calibration 
curves 
dgive the mean peak area for the calibration solution containing 1 ng/ml, as derived from the calibration curves 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 5 - Questionnaire 2 (narasin factors), page 3 
Remarks /Comments (if necessary, continue on another page) : 
s 
Please complete this questionnaire and return it together with representative chromatograms to: 
Ing. J.J.M. Driessen 
RIKILT 
P.O. Box 230 
6700 AE Wageningen 
The Netherlands 
Fax+31-317-417717 
Thank you for your cooperation ! 
Oorspronkelijk bericht 
^
a n :
 Driessen, ing. J.J.M. 
Verzonden: vrijdag 18januari 2002 11:45 
A a n : Antalick, J; Biancotto, Giancarlo; Cowles, John; Felgueiras, llidia; Fontaine, André; Haustraete, Karel; Henk van 
der Kamp; Muhonen, Raija; Nunes Costa, José; Pleger, Annette; Shearan, Paula; Thalmann, Alfred; Van 
Schalm, Klaas; Wehage, Hubert 
C C :
 Jong, Dr. J. de 
Onderwerp: Additional information 2nd coll. study Narasin 
Urgentie: Hoog 
Dear participant, 
With our covering letter 30596 of December 13th, 2001 concerning the 2nd collaborative study for narasin 
in a premixture we asked you to take note of the moisture content of the reference standard. This is a 
mistake! In agreement with the first ringtest the moisture content of the newly supplied standard should 
not taken into account!) 
A second remark concerns annex 5 regarding the factors for narasin. From the first collaborative study it is 
concluded that calculations only should be based on factor A. This means that only page 1 of annex 5 is 
of interest; so do not pay attention to pages 2 and 3. 
Those who sent already their results: please take note of this information; when the results have to be 
reconsidered send me please the corrected results. 
We apologize for this inconvenience and for the confusion it might have caused. 
Best regards, 
Jaap Driessen 
Coordinator CAN FAS collaborative study 
APPENDIX 2 
Composition and homogeneity of the premixture 
Recept: 3 27-560.2 
Fx UNIVERSEEL-MIX 1 % Versie: 2 
Ingangsdatum:14-03-00 
Kleur: Bruin Geur: Neutraal 
Verpakking: 20.00 KG 
Poedervormig Voormengsel voor Voeders voor: Diverse 
Diersoorten 
Inmengingspercentage : 
Berekende analyse : 
1 . 0 0 0 % 
*•/ / 'o MhnOo^ 
Naam P e r kg P r e m i x P e r kg E i n d v o e r 
Stortgewicht 
•Vitamine A 
•Vitamine D3 
•Vitamine E 
Vitamine K3 
Vitamine BI 
Vitamine B2 
d-Pantotheenzuur 
Niacine 
Biotine 
Vitamine B12 
Foliumzuur 
Vitamine B6 
Choline Chloride 
•IJzer 
•Koper 
•Zink 
•Mangaan 
•Cobalt 
•Jodium 
•Selenium 
Cd Tot. 
Pb Tot. 
Ruw Eiwit 
Ruw Vet 
Ruwe Celstof 
As 
Vocht 
Lysine 
Methionine 
Meth+Cys 
Threonine 
Tryptophaan 
Isoleucine 
Zetmeel Ewers 
Suiker 
Suiker/Zetmeel 
Calcium totaal 
Fosfor totaal 
Magnesium totaal 
Kalium totaal 
Natrium totaal 
Chloor totaal 
oP'97 plv 
oP'97 leg 
OE sik 
OE leg 
OE plv 
V.LysPLV 
V.MetPLV 
V.M+CPLV 
V.ThrPLV 
V.TryPLV 
Besch.P 
b.P.plv 
b.P.leg 
VEM 
VEVI 
+0.756 
+1000000.000 
+200000.000 
+2001.000 
+200.500 
+150.000 
+400.000 
+1200.000 
+2501.000 
+5000.000 
+2000.000 
+50.000 
+200.000 
+20001.000 
+7500.000 
+1000.000 
+5500.000 
+6001.000 
+20.000 
+80.000 
+30.000 
+0.517 
+16.845 
+93.537 
+20.586 
+47.282 
+460.000 
+68.881 
+3.208 
+1.253 
+2.958 
+2.657 
+1.103 
+2.557 
+117.496 
+25.065 
+142.561 
+105.859 
+4.512 
+25.359 
+6.560 
+1.021 
+5.236 
+1.203 
+1.203 
+681.759 
+979.527 
+960.979 
+2.082 
+0.863 
+1.938 
+1.581 
+0.808 
+1.053 
+1.053 
+1.053 
+419.081 
+439.634 
DVE mm T R O U W NUTRfflÖI^6 
•Hjlsp a nutreco company 
kg 
IE 
IE 
IE 
mg 
mg 
mg 
mg 
mg 
mcg 
mcg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
kcal 
kcal 
kcal 
g 
g 
g 
g 
g 
g 
g 
g 
g 
+0.008 
+10000.000 
+2000.000 
+20.010 
+2.005 
+1.500 
+4.000 
+12.000 
+25.010 
+50.000 
+20.000 
+0.500 
+2.000 
+200.010 
+75.000 
+10.000 
+55.000 
+60.010 
+0.200 
+0.800 
+0.300 
+0.005 
+0.168 
+0.935 
+0.206 
+0.473 
+4.600 
+0.689 
+0.032 
+0.013 
+0.030 
+0.027 
+0.011 
+0.026 
+1.175 
+0.251 
+1.426 
+1.059 
+0.045 
+0.254 
+0.066 
+0.010 
+0.052 
+0.012 
+0.012 
+6.818 
+9.795 
+9.610 
+0.021 
+0.009 
+0.019 
+0.016 
+0.008 
+0.011 
+0.011 
+0.011 
+4.191 
+4.396 
+0.215 
kg 
IE 
IE 
IE 
mg 
mg 
mg 
mg 
mg 
mcg 
mcg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
kcal 
kcal 
kcal 
g 
g 
g 
g 
g 
g 
g 
g 
g 
c 
CANFAS 
<. 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
j 
Homogeneity test 2nd collaborative study 
Additive 
Product 
Narasin 
Premixture: 1.0% 
homogeneity 
Criterion : CV, 
Avi 
Date of determination : 
Sample 
133101-a 
133101-b 
133105-a 
133105-b 
133112-a 
133112-b 
133119-a 
133119-b 
133125-a 
133125-b 
133126-a 
133126-b 
133127-a 
133127-b 
133128-a 
133128-b 
133129-a 
133129-b 
133130-a 
133130-b 
November 21 th, 
Content 
(%) 
1,0130 
1,0644 
1,0255 
1,0735 
1,0775 
1,0364 
1,0955 
1,1365 
1,0877 
1,0285 
1,0345 
1,1166 
1,0703 
1,0620 
1,0485 
1,0907 
1,0216 
1,0371 
1,0520 
1,0961 
2001 
Duplicate 
average 
% 
1,04 
1,05 
1,06 
1,12 
1,06 
1,08 
1,07 
1,07 
1,03 
1,07 
between <7% 
OK 
erage 
D (between samples) 
CV (between samples) 
Qrubb's test, single lower 
njbb's test, single upper 
J^bb's test, double lower 
Njbb's test, double upper 
'
xePeatability 
S D
 (within samples) 
SjMthin samples) 
(sdr) 
(CV (%)) 
1,06 
0,033 
3,1% 
1,190 
2,143 
0,5693 
0,3262 
Result Grubb's test 
no outlier 
no outlier 
no outliers 
no outliers 
0,034 
3,2 
'-2002 Narasin premixture.XLS JD 
APPENDIX 3 
Sample codes 
Sample codes supplied to the participants in the narasin collaborative study 2nd round 
Lab 
11 
13 
23 
24 
26 
29 
30 
31 
33 
35 
37 
41 
premixture 1 % 
113106 
133123 
233121 
243117 
263124 
293107 
303118 
313114 
333103 
353122 
373115 
413116 
APPENDIX 4 
Narasin reference standard profile 
CONFIDENT! A L 
DISTRIBUTION TO LILLY PERSONNEL ONLY 
ELI LILLY AND COMPANY 
PRODUCT DEVELOPMENT OPERATIONS DIVISION 
REFERENCE STANDARD PROFILE 
Effective Date : March 29,2001 
Expiry Date: March 28, 2003 
Supersedes Date: November 2,2000 
Compound:079891 
£gyjsj2ii:22 
Hams: Narasin 
Lot Number: RS0302 
Defined Potency : 963 meg microbiological activity per mg on an 'as is' basis; 85.4% factor A, 1.9% 
factor D, and 0.7% factor I on an 'as is' basis (See Note). 
Handling Refer to current MSDS for handling and caution information. 
Storage: 125 mg quantities in heat sealed amber glass ampoules with argon overlay at freezer 
temperature, -10 to -25 C. 
* Evolution: Lot RS0302 (bulk lot H93-NXK-394235678 was reevaluated in March 2001. 
Tests 
(x) *HPLC Assay (Method B01795) 
•HPLC Factor Composition, Factor A 
(Greenfield Ntbk. NB-NBK-1879) 
*HPLC Factor Composition, Factor B 
(Greenfield Ntbk. NB-NBK-1879) 
•HPLC Factor Composition, Factor D 
(Greenfield Ntbk. NB-NBK-1879) 
*HPLC Factor Composition, Factor I 
(Greenfield Ntbk. NB-NBK-1879) 
HPLC Factor Composition, Unknown 
(Greenfield Ntbk. NB-NBK-1503) 
(x) Microbiological Assay (Method BO0175, 
pH 5.2) 
Cation Screen, Ion Chromatography 
(Method RP29) 
Anion Screen, Ion Chromatography 
(Method RP35) 
949 meg/mg on an 'as is' basis versus lot 
RS0306 (n=18) 
85.0% vs. narasin factor A reference standard 
lotRS0306(n=21) 
None detected vs. narasin factor B reference 
standard lot RS0297 (n=21) 
2.2% vs. narasin factor I reference standard lot 
RS0305 (n=21) 
0.6% vs. narasin factor I reference standard lot 
RS0305 (n=21) 
0.4% vs. narasin factor I reference standard lot 
RS0305 (n=128) 
913 meg per mg vs. narasin factor A reference 
standard lot RS0306 (n=62) 
Li+, NH4(+), K(+), Mg(2+), and Ca(2+) were 
not detected (n=l) 
F-, N02(-), N03(2-), Br(-), P04(3-), and 
S04(2-) were not detected (n=l) 
Page 2 
Narasin 
Metal Screen, ICP (Method RP40) 
(x) *X-ray Pattern (Method RP18) 
1H NMR Spectrum 
13C NMR Spectrum 
TGA (Method RP9) 
Water, KF (Method RP19) 
Fatty Acids, GC 
Al, B, Ba, Bi, Cd, Co, Cr, Cu, Fe, Mg, Mn, 
Na, Pb, Pd, Pt, Sb, Si, Sn, V, Zn, and Zr were 
not observed at the 0.08% level; Ca detected 
but was much less than 0.08% (n=l) 
Pattern compares favorably to the previous 
pattern of this lot; material is crystalline (n=l) 
Spectrum is consistent with the structure and has 
been filed for future reference (n=l) 
Spectrum is consistent with the structure and has 
been filed for future reference (n=l) 
The thermograms show a weight loss beginning 
at 25 C which results in a 2.0% loss at 113 C 
(n=8) 
2.13 % (n=72) 
3.9% (n=l) 
Note: (x) indicates the standard material is approved for use as a reference for the test 
The microbiological potency was determined from the overall average of the initial HPLC and autoturb 
assays performed by GL757, GL791, and CL44C (n=188, Greenfield Ntbk. NB-NBK-1503) 
* Revised March 21,2001 
Beverly J. Krabel 
Revision 22 
APPENDIX 5 
Table with results, questionnaire (page 1) and chromatograms 
of partner 11 
CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 04-02-2ÖÖ2J 
Analyte: 
Product: 
e-mail: 
fax: 
telephone: 
| NARASIN | 
| Premixture 
Unit 
Sample code 
113106 
Result 1 
(mg/kg) 
10267 
Result 2 
(mg/kg) 
10495 
/ / 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4 - Questionnait 
Laboratory: , 
Contact person: 
°ate(s) of analysis: ^' °2~ c'2 
Chcomatopraphir conditions; 
• Column: 
• & A s described in the method 
• D Other: 
• Mobile phase: 
• ^ A s described in the method 
• D Other: 
• Rotate: . . . .$ .£ ml/min 
• Injection volume: .J.O.O..... pi 
^facamatograms: Please include representative chromatograms of: 
' Premixture 
fease indicate the narasin factor A peak (and the factor D/l peak, see Annex 5) with an arrow 
ßfiCDJffirxissuJis: 
1
 Percentage recovery: lùL.% 
Single / duplicate determinations: • single fe( duplicate 
K duplicate, please give both percentages:.%. % and / / .«. . % 
Spiking level:...5.Q... mg/kg 
ak Report *** 
hNO TIME 
1 22.019 
AREA MK 
53050 S 
PURITY.UP PURITY.DOWN IDNO CONC 
0.9984(0.9587) 0.9990(0.9722) 1 10603.3477 
53050 10603.3477 
47 1/1 02/02/05 09:12:2 
APPENDIX 5 
Table with results, questionnaire (page 1) and chromatograms 
of partner 13 
CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 03-01 -2002~| 
Analyte: 
Product: 
J e-mail: 
fax: 
telephone: 
NARASIN 
| Premixture | 
Unit 
Sample code 
133123 
Result 1 
(mg/kg) 
10667 
Result 2 
(mg/kg) 
10713 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4 - Questionnaire 
Laboratory: 
Contact person: 
Date(s) ofanalysis: ...^r.P.h*??. 
£bfomatngrflr>f|jr renditions; 
• Column: 
• SS As described in the method 
• D Other: 
• Mobile phase: 
• a As described in the method 
• 0 Other: 
• FlovH-ate: ..9.J. ml/min 
* Injection volume: ..I.9.Q....pi 
Chtamatograms- Please inc lue r f tpr»*«"*^™ chromatoErams of. 
• Premixture 
please indicate the narasin factor A peak (and the factor D/l peak, see Annex 5) with an arrow 
* Percentage recovery: % 
* Single/duplicatedetejOTfflSfions:D single o duplicate 
* f duplicjjg<pl6asegive both percentages: % and % 
fflong level: mgAg 
1 NarasinCANFAS 
18.1.02 8:33 A* 
Sample Name: 
Vial Number 
Sample Type: 
Control Program: 
Quantif. Method: 
Recording Time: 
Run Time (min): 
NarasinCANFAS 
1 
^mmmmmm 
NarastaCANFÀS 
3.1.02 10:48 
23,00 
Injection Volume: 
Channel: 
Wavelength: 
Bandwidth: 
Dilution Factor 
Sample Weight: 
Sample Amount: 
100,0 
UV VIS 1 
600 
n.a. 
1,0000 
1,0000 
^HpOOO 
. .„ ,« Canfas 03.01.02*1 13,00 i . . B l 
' mV 
12,00-
NarasinCANFAS UV V1S_1 
11,00-
10.00-
8.00^ 
8,00-
7,50-
iw>^srwvv*vvniww^/»vv* , ,^v»v iO''^iWi w »*wv i 
WVL600ntr 
1-N«nwin-19.5<3 
I I ' » " " f '" t • '* " 1 •••• I I • •! • ! • • • . -
2,5 5.0 7.5 
»' » r»1 ! • • i i ' i i i t r i l f » 
10,0 12.5 
' I ' ' 
15.0 JPA. 20.0 23.0 
No. 
1 
Total: 
RetTlme 
min 
19.54 
Peak Name 
Narasin 
Height 
mV 
4.302 
4,302 
Area Rel-Area 
mV*mln % 
2.215 100.00 
2,215 100,00 
Amount 
mg/kfl 
496.953 
496,953 
Type 
BMB* 
s 
14 F 3913 c 133213 
Sample Name: 
Vial Number. 
Sample Type: 
F 3913 c 
6 
unknown 
Control Program: NarasinCANFAS 
Quantif. Method: 
Recording Time: 3.1.0216:01 
Run Time (min): 23,00 
12,00-
Canfas 03.01.02*14 
11.00H 
10.00H 
9.00H 
8.00H 
7,50-
biV 
0,0 
- r — . — i — r ~ 
5.0 
No. 
L-JL 
Total: 
RetTlme 
min 
Peak Name 
19.49 Narasin 
Injection Volume: 
Channel: 
Wavelength: 
Bandwidth: 
Dilution Factor 
Sample Weight: 
Sample Amount: 
100,0 
UV_V!S_1 
600 
n.a. 
1,0000 
400,0000 
1,0000 
F 3913 c 133213 
10,0 
UVVIS 1 
WVL600 nm 
1-Narasin-1M17 
mm 1 i r-
15,0 20,0 23,0 
Height Area Rei.Area Amount Type 
mV mV*min % % 
flfiB5 1,888 100.00 1.064 BMB 
3 685 1,888 100,00 1,084 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
j Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 07-01-2002] 
Analyte: | 
Product: | PremixtuTe"] 
e-mail: 
fax: 
telephone: 
NARASIN 
Unit 
Sample code 
233121 
Result 1 
(mg/kg) 
12000 
Result 2 
(mg/kg) 
10800 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
! Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Product: 
Task 4 COLLABORATIVE STUDY - 2nd round 
22nd Jan 2002 
Je-mail: 
fax: 
telephone: 
| NARASIN | 
| Premixture 
Unit 
Sample code 
243117 
Result 1 
(mg/kg) 
10801 
Result 2 
(mg/kg) 
9950 
2lf 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4 > QiiAttionnatre 
Laboratory:..... 
Contant person: 
Date(s) of analysis: . . . . .^ .^ . . . . . fc- . t . r .^ . . . . . . *^ . * : . 
Chromatographic conditions; 
• Column: 
• o As described in the method . 
• a other: ^V.&yA.&Kr.^. Crfîf......Qo. (XXf?,./f.^..ft.).4*ihf,. 
• Mobile phase: 
• ^ A s described in the method 
• D Other: 
• Row-rote: ......&.$.... mfrrtin 
• Injection volume: .//4W?...ul 
ChtpmatQgramt: Plaa«ft Inriiida rwpreypirtaHva chrnmatofframe eft 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/l uttak, see Annex 5) uith m arrow 
fiecûiEouciuIta; 
• Percentage recovery; .If?.. % 
• Single/duplicate determinations:^ single o duplicate 
• If duplicate, please give both percentages: % and X 
• Spiking level: ....Sfc?. mg>*g 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Product: 
Task 4 COLLABORATIVE STUDY - 2nd round 
9-1-2002 
J e-mail: 
fax: 
telephone: 
I 
| Premixture 
Unit 
Sample code 
263124 
NARASIN 
Result 1 
(mg/kg) 
11887 
I 
Result 2 
(mg/kg) 
10612 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4 - Questionnaire 
Laboratory:.... 
Contact person: 
Date(s) of analysis: l.'.^Jli?.. 
Chromarnffraphip rionditiffl'il 
• Column: 
• a As described in the method 
• mother: ..Wtt.té.f...J?!^SoÇ£. ^^.^...^^...„^JTO^ * W- £»w. 
• Mobile phase: 
• D'As described in the method 
• o Other: 
• Flowate: ...$&&... ml/min 
• Injection volume: .../..<&..pi 
Chtomatograme; P|ease include representative chromatogramg oft 
• Premixture 
Mease indicate the narasin factor A peak (and the factor D/I peak, see Annex 5) with an arrow 
fifiCûJffirxifisutts: 
* Percentage recovery:..!.". % 
* Single/duplicate determinationsrtefsingle o duplicate 
* If duplicate, please give both percentages: % and % 
* Spiking level: .3$?.. mg/kg 
:
.+03!MV NARASINTRIAL090102018.CH3 
•+03 
i+03 
:+03 
•+03 
•+00 
^WW^W^WV 
.fet 
1 -é- NPriZ-A-S' rS 
TSJM 
K
^mm^mmm^j^/\^ J 
25.00 ^ 0 . 0 0 f 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - R e p o r t fo rm 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: |18.01.2002 
Analyte: 
Product: 
e-mail: 
fax: 
telephone: 
NARASIN 
Premixture] 
Unit 
Sample code 
293107 
Result 1 
(mg/kg) 
10935 
Result 2 
(mg/kg) 
9902 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4 - Questionnaire 
Date(s) of analysis: \^.....^)^^....2.Q9.'^. 
;a in uie meuiua 
Chromatographie conditions: 
• Column: 
• a As described in the method 
• «Other: 
• Mobile phase: 
• ST As described in the method 
• a Other: 
• Flow-rate:.... A ?• ml/min 
• Injection volume: ...wy...pi 
Chromatograms: Please include representative chromatngr^m^ ftft 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/1 peak, see Annex 5) with an arrow 
Recovery results: 
• Percentage recovery: töf^T % 
• Single / duplicate determinations: a single J& duplicate 
• If duplicate, please give both percentages: K*fi% and $%.l. % 
• Spiking level: . .5Q. . . mg/kg 
Samples 
Project Name: Narasin_CANFAS 
S A M P L E I N F O R M A T I O N 
Sample Name: 
Vial: 
Premixture 2931071 dil2/50 
35 
Injection #: 1 
Injection Volume: 100,00 ul 
Processing Method: Nar 18_01_2002 
Run Time: 20,0 Minutes 
Proc. Chnl. Descr.: PEA 600,0 nm 
0,035 
0,030-
0,025 
0,020: 
0,015 
0,01(h 
0.005-
0,000-
Auto-Scaled Chromatogram 
I 1 1 1 1 1 1 . 1 1 1 ! 1 1 
2,00 4,00 6,00 8,00 
I McUûSrf'n / , 
-T 1 1 1 1 1 1 1 1 — | 1 1 1 1 1—i r 
10,00 12,00 14,00 16,00 18,00 20.00 
Mnutes 
Peak Results 
1 
Name 
Narasina 
RT 
17,145 
Area 
904316 
Height 
33574 
Amount 
10,935 
Units 
ug/irt 
Result : mo/kg narasin 
C = 
V x A x D 
w 
A - amount (ug/mJ) 
D - dilution fector 
w-weight 
V-volume 
C 1QQ36 ma/ka natasin 
A - 1 Ö ^ 3 5 ^ / * u 4 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 • Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 21-01-2602] 
Analyte: 
Product: | Premixturë] 
Je-mail: 
fax: 
telephone: 
[ NARASIN 
Unit 
Sample code 
303118 
Result 1 
(mg/kg) 
10320 
Result 2 
(mg/kg) 
10260 
30 
CANFAS COLLABORATIVE STUDIES DECEMBER 2 0 0 1 - NARASINI 
Annex 4 - Questionnaire 
Laboratory: « 
Contact person:... 
Date(s) of analysis: Z.SfJ.Q.M&Z*. 
Chromatographic conditions: 
• Column: 
• n As described in the method 
• prOthen fcCKÄ.NWOU^ß J..f.(Ltf...(lf&..x>U}A 
• Mobile phase: 
• fc£As described in the method 
• D Other: , 
• Rowrate: ...G^.o. m(/min 
• injection volume: ,*40U...pl 
qiromirfftprama.' Please include representative fthramatapram» of; 
• Prembcture 
Please indicate the narasin factor A peak (and the factor D/i peak, see Annex AT with an arrow 
Rfifinvfiry resuMs; 
• Percentage recovery: % 
• Single/duplicate determinations: D single a duplicate 
• H duplicate, please give both percentages: % and % 
• Spiking level: mgAg 
1,0 
Ï0.0O-J 
I9.0CH 
18.00-
7M-
6.0fr 
5.00-
*°°: 
3.00^  
10fr' 
1.00-
KOfr 
1.00-
1.00-j 
'.00-
100-j 
.Ofr' 
.00-; 
.00-
«H 
ooH. i i i i i i i ' i i • 
2.00 <00 CM» 
-i—r-r-
B.00 
I I I I I I I • I T 
10.00 12.00 
i i •—' ' r 
14.00 1R00 ie!oo TD'M 2Si00 
Minute« 
• I i i i I i i i i i ' 
24.00 26.00 28.00 ? 
McsLX<\&^>r\ ZSoli ^j/wit 
lOO-
'oo: 
1,00" 
i.00-
«* : 
•<& 
i 
3,0 
T S — 
-i—nn—i—|—r—i—r—T—T—T—i—|—i—i i |—i—i—i—|—r'"i i—|—i—r—i—|—i—i—r-7—'—r—1—| 1 1 1—f—"—f ' • 1 1 1—r—1—1 1 1 
4.00 6.00 8.00 10.00 1200 14.00 18.00 18.00 20.0* 22.00 24.00 28.00 28.00 90X 2.UÜ 
Minuteo 
>rÄVYSA>- T , J - * " « -rïuL\ 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
A N N E X 2 - R e p o r t f o r m 
CANFAS 
i Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: j 03-01-2002] 
Analyte: | 
Product: | Premixture"! 
e-mail: 
fax: 
telephone: 
NARASIN 
Unit 
Sample code 
313114 
Result 1 
(mg/kg) 
10779 
Result 2 
(mg/kg) 
10778 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4 • Questionnaire 
Date(s) of analysis: ....C?Z.-&Lfr...L.Q.Q.Zr.. 
Chromatogranhir conditions: 
• Column: 
• 0JVs described in the method 
• D Other: 
• Mobile phase: 
• H.AS described in the method 
• D Other: 
Flowfate: Q.fh.... m|/min 
• Injection volume: ...IfóQ.ui 
Chromatograms: Please include representative chromatogratm of: 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/Ipeak, see Annex 5) with an arrow 
Recovery results; 
• Percentage recovery: )OL%% 
• Single/duplicate determinations:^ single D duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: mg/kg 
Page 1 of 1 
•ftware Version 
mple Name 
itrument Name 
ick/Vial 
mple Amount 
de 
6.1.2.n.1rD19 
0/0 
1,000000 
9 
J t fmp^ Date Data Acquisition Time 
Channel 
Operator 
Dilution Factor 
15-1-02 14:00:09 
3-1-02 15:27:04 
A 
1,000000 
Time [min] 
narasin 
ak Time Component 
! [min] Name 
1 22,57 nar-A 
2 26,57 nar-D 
3 27,40 Nar-I 
Area 
[MVs] 
Height 
[MV] 
Area Norm. Area BL Area/Height 
[%] 
521936,00 15033,18 95,86 
10338,47 267,49 1,90 
12183,53 294,87 2,24 
544458,00 15595,53 100,00 
ssing Component Report 
mponent Expected Retention (Calibration File) 
[%] 
95,86 BB 
1,90 BV 
2,24 VB 
100,00 
[s] 
34,7189 
38,6502 
41,3181 
components were found 
Page 1 of 1 
ftware Version 
mple Name 
trument Name 
ckA/ial 
mple Amount 
cie 
: 6.1.2.0.1:019 
: std 10.00 ug/ml 
: HPLC-1 
: 0/0 
1,000000 
4 
Date 
Data Acquisition Time 
Channel 
Operator 
Dilution Factor 
15-1-02 14:07:58 
3-1-02 12:38:50 
A 
1 .ouuuuu 
iPr 
I I 
TTT 
9 3 
I * 
TTTTTT 
10 12 14 16 18 20 22 24 26 28 
Time [min] 
narasin 
ak Time Component 
1
 [min] Name 
1 22,72 nar-A 
2 26,66 nar-D 
3 27,48 Nar-I 
Area 
[uV-s] 
484728,00 
5738,49 
8768,51 
Height 
[uV] 
13712,84 
156,14 
224,48 
Area 
[%] 
97,09 
1,15 
1,76 
Norm. Area BL Area/Height 
[%] [s] 
499235,00 14093,47 100,00 
ssing Component Report 
mponent Expected Retention (Calibration File) 
97,09 BB 
1,15 BV 
1,76 VB 
100,00 
35,3485 
36,7511 
39,0609 
components were found 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
I Development and Validation of HPLC-methods for the official control of 
iCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Product: 
Task 4 COLLABORATIVE STUDY - 2nd round 
21-12-2001 
J e-mail: 
fax: 
telephone: 
| NARASIN | 
| Premixture 
Unit 
Sample code 
333103 
Result 1 
(mg/kg) 
12000 
Result 2 
(mg/kg) 
12000 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4 - Questionnaire 
Laboratory:.. 
Contact person:... , 
Date(s) of analysis: ....f&/-W/ft7 
Chromatographic conditions: 
• Column: 
• ^ A s described in the method 
• G Other: 
• Mobile phase: 
• J£As described in the method 
• a Other: , 
• Flow-rate: ...G^ ml/min 
• Injection volume: So. ul 
Chromatograms: Please include representative chromatograms of: 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/I peak, see Annex 5) with an arrow 
Percentage recovery: Jt&. % 
Single /duplicate determinations: ^ s ingle a duplicate 
If duplicate, please give both percentages: % and % 
Spiking level: .S.0 mg/kg 
0.014-
0.013-
0.012-
0.011-
0.010-
0.009-
0.008-
0.007-
0.006-
£ 
0.005-
0.004-
0.003-
0.002-
0.001-
0.000-
•0.001-
' — I — i — i — i — l — l — i — i — i — i — i — ' — • — i — i — i — > 
1.00 2.00 3.00 4.00 
- i 1 1 1 1 1 1 1 1 1 r 
5.00 
Minutes 
6.00 
— | 1 1 1 1 1 ! 1 1 1 1 1 
7.00 8.00 9.00 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
I Development and Validation of HPLC-methods for the official control of 
jçpccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 23-01-2ÔÔ2] 
Analyte: | 
Product: | Premixture 
Je-mail: 
fax: 
telephone: 
NARASIN 
Unit 
Sample code 
353122 
Result 1 
(mg/kg) 
10812 
Result 2 
(mg/kg) 
10539 
CANFAS COLLABORATIVE STUDIES DECEMBER 2 0 0 1 - NARASIN 
Annex 4 - Questionnaire 
Laboratory: 
Contact person: 
Date(s) of analysis: 23 j a n u a r i 2002 
Chromatographic conditions: 
• Column: 
• a As described in the method 
• Ä Other: . .ChrpmSphex. . . lÛO 3jnm aX 
• Mobile phase: 
• H As described in the method 
• D Other: 
• Flovwate: ?..'.?. m|/min 
• Injection volume: ...?.?.....pi 
Chromatograms: Please include representative chromatograms of: 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/lpeak, see Annex 5) with an arrow 
Recovery results: 
• Percentage recovery: ...aä^fö- /O 5^/* 
• Single/duplicate determinations: a single {^duplicate 
• If duplicate, please give both percentages:....,.% and % 
• Spiking level: /.ÛQÔ... mg/kg 'Û*'V /täf. 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
23-01-2002 
Je-mail: 
fax: 
telephone: 
Date of analysis: 
Analyte: 
Product: | Premixture"] 
NARASIN 
Unit 
Sample code 
373115 
Result 1 
(mg/kg) 
10560 
Result 2 
(mg/kg) 
9960 
CANFAS COLLABORATIVE STUDIES DECEMBER 2 0 0 1 - NARASIN 
Annex 4 - Questionnaire 
Laboratory:.... 
Contact person: 
Date(s) of analysis: .Â2&1.1 lQ£rr.. 
nhmmflfngraphir: conditions: 
• Column: 
• D As desenbed in the method 
• D Other: .^£^.tk...^M..]&3..GJ8;jQ?.$£?ï..*..\kikMttf. 
• Mobile phase: 
• B'Äs described in the method 
• a Other: 
• Flow-rate: ..JQ.:.ct. mi/min 
• injection volume: -lQö....ui 
ChmmaMfram« Please Include repräsentative ehrnmamframg af: 
• Premixture 
fifeosc indcate the narasm factor A peak tand the fantnr 0/I peak, see Annex 5) with an arrow 
RprnvBfV rpgutts? 
> Percentage recovery: 133:3% 
• Singlo/ duplicate determinations: D single ffl^aupBoatB 
• It duplicate, please give both percentages:%% % and .?&. % 
• Spiking level: . . .3£.. . rng/T« 
1st run PC1000 MUIMMISÎII/PS 
Mode: Reproccsood Data 
Original Results- n:\TSP\RYSTEMl\Data\collnar230102psA.RES 
Reprocessed Results: D:\TSP\SYSTEM1\Data\collnar230102psA.RMS 
Pagel 
Reported On: 25-01-102 12:00:0* 
Nam«: premUa 
Description: PremlxA (1/100) 
Typo: Sample 
Vial: A06 
Acquisition Log 
Column Pressure»: N/A 
Noise (microAU): 2CH-001 
Run-Time Messages: Nlnnn 
Column Temperature (C): N/A 
Drift (microAU/min): -3e+001 
Calculation Type: External Standard (Area) 
mv or mAU 
M M en 
S 
UI 
o». 
O 
: =
—"25.317 narasin W f t o ß . A 
3 
l 
s-ï I 
(A 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2-Repor t form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 21-01-20Ö2I 
Analyte: 
Product: 
Je-mail: 
fax: 
telephone: 
NARASIN 
| Fremixture" 
Unit 
Sample code 
413116 
Result 1 
(mg/kg) 
9976 
Result 2 
(mg/kg) 
10122 
CANFAS COLLABORATIVE STUDIES DECEMBER 2001 - NARASIN 
Annex 4 - Questionnaire 
Laboratory: 
Contact person:. 
Date(s) of analysis: #/.o/r £00^ 
Ohmmatopranhic conditions: 
• Column: 
• ÄAs described in the method 
• G Other: < 
• Mobile phase: 
• sf As described in the method 
• D Other: 
• Flow-rate: ...QA.X.... m|/min 
• Injection volume: / # # . . . u l 
Chromatoerams: Please include representative chromatograms of: 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/1 peak, see Annex 5) with an arrow 
Recovffry results: 
• Percentage recovery: 7Z.r.% 
• Single / duplicate determinations: o single Hf duplicate 
• If duplicate, please give both percentages:/^ S. % an</.../.!.% 
• Spiking level: LQ..P... mg/kg 
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